Checkpoint kinase-1 inhibition and etoposide exhibit a strong synergistic anticancer effect on chronic myeloid leukemia cell line K562 by impairing homologous recombination DNA damage repair

Leukemia, a malignant hematological disease, has poor therapeutic outcomes due to chemotherapeutic resistance. Increasing evidence has confirmed that the elevated capacity for DNA damage repair in cancer cells is a major mechanism of acquired chemotherapeutic resistance. Thus, combining chemotherapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Zhuoyi, Luo, Huacheng, Zhou, Jie, Wang, Fangce, Zhang, Wenjun, Wang, Jian, Li, Shuo, Lai, Qian, Xu, Yueshuang, Wang, Guangming, Liang, Aibin, Xu, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7551253/
https://www.ncbi.nlm.nih.gov/pubmed/32901871
http://dx.doi.org/10.3892/or.2020.7757

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7551253/
https://www.ncbi.nlm.nih.gov/pubmed/32901871
http://dx.doi.org/10.3892/or.2020.7757

Ejemplares similares